INTELLIGENT BIO SOLUTIONS INC. Accounts Payable and Accrued Liabilities
INTELLIGENT BIO SOLUTIONS INC. (INBS) had Accounts Payable and Accrued Liabilities of $1.04 million as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Liabilities › Accounts Payable and Accrued Liabilities
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent · last filed 2022-11-14
- 2022-09-30: Accounts Payable and Accrued Liabilities $1.04M.
- 2022-06-30: Accounts Payable and Accrued Liabilities $1.63M.
- 2022-03-31: Accounts Payable and Accrued Liabilities $884.28K.
- 2021-12-31: Accounts Payable and Accrued Liabilities $448.89K.
| Period end | Accounts Payable and Accrued Liabilities | Accounts Payable and Accrued Liabilities as first filed |
|---|---|---|
| 2022-09-30 | $1.04M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $1.63M 10-Q · filed 2022-11-14 | |
| 2022-03-31 | $884.28K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $448.89K 10-Q · filed 2022-02-11 | |
| 2021-09-30 | $808.74K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $1.47M 10-K · filed 2022-09-22 | $1.61M 10-K · filed 2021-09-16 |
| 2021-03-31 | $1.58M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $752.77K 10-Q · filed 2021-02-12 | |
| 2020-06-30 | $2.56M 10-K · filed 2021-09-16 | $787.47K 10-Q · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |